Pediatric and Strabismus Care: Evolving Tools, Emerging Therapies
Pediatric ophthalmology is undergoing a significant transformation thanks to advances in imaging, diagnostics, genetics, and treatment options. Experts interviewed in the article explain that technologies such as handheld optical coherence tomography (OCT), widefield retinal imaging, and tele-ophthalmology are making it easier to diagnose and monitor eye conditions in infants and young children, even in patients who cannot cooperate with traditional examinations. These tools are helping clinicians detect diseases earlier, improve access to specialist care, and better monitor conditions such as glaucoma, retinal disease, and neuro-ophthalmic disorders. Researchers are also exploring artificial intelligence and smartphone-based screening tools that could one day identify refractive errors and strabismus quickly and accurately in community settings.
One of the biggest advances discussed is the evolving treatment of amblyopia, commonly known as “lazy eye.” While traditional therapies such as patching the stronger eye and correcting refractive error with glasses remain effective, new binocular digital therapies are changing how children are treated. These FDA-approved treatments use specially designed video games or movies to stimulate both eyes simultaneously, making therapy more engaging for children and less stressful for families. According to the specialists, these therapies have shown promising results even in children who did not respond well to conventional treatment, and some are now approved for patients up to 12 years of age. The experts also note that correcting eye alignment through strabismus surgery may enhance the effectiveness of binocular amblyopia therapy by restoring better coordination between the eyes.
The article also highlights the importance of early detection of strabismus, particularly in children who are at higher risk due to prematurity, low birth weight, neurological disorders, or a family history of eye disease. Routine vision screening by primary care providers remains essential, but newer technologies are improving the accuracy of these screenings. One example is a binocular retinal scanning device capable of detecting even subtle forms of strabismus that traditional photoscreeners may miss. Earlier identification allows treatment to begin sooner, reducing the risk of permanent vision loss from amblyopia and improving the chances of developing normal binocular vision and depth perception.
Perhaps the most exciting developments are occurring in the field of inherited retinal diseases. The experts describe how gene therapy has already changed the outlook for certain conditions, including Leber congenital amaurosis caused by RPE65 mutations, with additional therapies now progressing through clinical trials for disorders such as X-linked retinitis pigmentosa and Stargardt disease. Researchers are investigating both gene-specific treatments and gene-agnostic approaches, as well as oral medications that may slow disease progression. These advances offer new hope to families facing previously untreatable childhood retinal disorders and signal a future in which inherited blindness may become increasingly preventable or treatable.
Overall, the article paints an optimistic picture of the future of paediatric ophthalmology. Innovations in imaging, artificial intelligence, digital therapeutics, surgical techniques, and gene therapy are converging to improve both the diagnosis and treatment of childhood eye diseases. While many of these technologies are still emerging, they are already reshaping clinical practice and expanding the options available to clinicians and families. The experts emphasize that earlier diagnosis, more personalized treatment, and continued investment in research are likely to produce even better visual outcomes for children in the years ahead.
To learn more:
